Particular person neurons are labeled with fluorescent proteins utilizing the brainbow method. In researching psychedelics and ketamine, researchers goal to grasp how medication like psychedelics and ketamine might enhance the variety of connections between neurons.
Sergi Reboredo/VW Pics/Common Photos Group by way of Getty Photos
cover caption
toggle caption
Sergi Reboredo/VW Pics/Common Photos Group by way of Getty Photos
Particular person neurons are labeled with fluorescent proteins utilizing the brainbow method. In researching psychedelics and ketamine, researchers goal to grasp how medication like psychedelics and ketamine might enhance the variety of connections between neurons.
Sergi Reboredo/VW Pics/Common Photos Group by way of Getty Photos
This week on NPR’s Brief Wave podcast, we’re diving into the science behind medication like psychedelics and ketamine.
Thus far, we have heard from scientists attempting to untangle the consequences of the “journey” that usually comes with these medication from the methods they may change the human mind.
Some researchers level out that the journey makes the medication inaccessible for some sufferers. For instance, sufferers with a historical past of bipolar dysfunction or schizophrenia cannot take psychedelics or ketamine. Others could merely not wish to journey or have out-of-body experiences in any respect.
In each circumstances, a non-hallucinogenic drug might assist bridge the therapy hole. So firms like Delix Therapeutics are making new medication impressed by psychedelics — with out the journey.
However there are nonetheless questions throughout the subject about what facet of those medication is most vital for sufferers. Some researchers emphasize the significance of the experiential journey part of psychedelics. Others are optimistic that non-hallucinogenic medication could widen therapy choices for sufferers.
Take heed to the primary episode of the sequence right here and the second episode right here. Catch the remainder of this sequence on psychedelics and associated medication this week by following us on Spotify and Apple Podcasts.
Produce other questions on psychedelics and the mind? Tell us by emailing shortwave@npr.org!
This episode was produced by Hannah Chinn. It was edited by Rebecca Ramirez and Geoff Brumfiel. Tyler Jones checked the details. Maggie Luthar was the audio engineer. Particular because of Jon Hamilton.
